No Seroreversion in Long-Term HAART-Treated HIV Patients
Author Information
Author(s): Marion Cornelissen, Suzanne Jurriaans, Jan M Prins, Margreet Bakker, Antoinette C van der Kuyl
Primary Institution: Academic Medical Centre, University of Amsterdam
Hypothesis
Does effective HAART treatment during chronic HIV-1 infection lead to seroreversion?
Conclusion
Successful HAART treatment during chronic HIV-1 infection does not induce seroreversion.
Supporting Evidence
- None of the patients showed seroreversion after five years of HAART.
- Antibody levels did not significantly change after five years of treatment.
- Patients with blips did not show a significant difference in antibody levels compared to those without.
Takeaway
The study found that patients who have been treated for HIV for a long time and have no detectable virus in their blood do not lose their antibodies to the virus.
Methodology
The study analyzed HIV-1 antibody levels in 80 patients treated with HAART for at least five years with undetectable plasma viral load.
Limitations
The study does not address the possibility of patients with no replication of HIV existing in this group.
Participant Demographics
All participants were HIV-1 seropositive patients treated with HAART.
Statistical Information
P-Value
0.056
Statistical Significance
p = 0.95
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website